Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics;Wystȩpowanie w materiałach klinicznych i ocena oporności na wybrane antybiotyki szczepów Proteus mirabilis

Polski Merkuriusz Lekarski

Volumn 17, Issue 101, 2004, Pages 538-540

  Sȩkowska, Alicja ^a   Janicka, Grazyna ^a   Wróblewska, Joanna ^a   Kruszyńska, Ewa ^b  

^a AM ^*  (Poland)

^b Katedra Mikrobiologii   (Poland)

Author keywords

Clinical specimens; Proteus mirabilis; Resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM ISOLATE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; NONHUMAN; OPPORTUNISTIC INFECTION; PROTEUS MIRABILIS; REVIEW; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PROTEUS MIRABILIS;

EID: 10844233896     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Chanal C. i wsp.: Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital. Antimicrob. Agents Chemother., 2000, 7, 1930-1935.
2. Goldstein F.W.: Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur. J. Clin. Microbiol. Infect. Dis., 2000, 19, 112-117.
3. Hryniewicz W.: Problemy opomości na antybiotyki u najczȩstszych patogenow szpitalnych. Nowa Medycyna, 1998, 11, 3-7.
4. Huei S.W. i wsp.: Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan. Diagn. Microbiol. Infect. Dis., 2002, 43 (2), 141-147.
5. Kahlmeter G.: An international survey of the antimicrobial suceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J. Antimicrob. Chemother., 2003, 51 (1), 69-76.
6. Karlowsky J.A. i wsp.: Trends in antimicrobial susceptibilities among enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob. Agents Chemother., 2003, 47 (5), 1672-1680.
7. Loomes L.M., Senior B.W., Kerr M.A.: Proteinases of Proteus spp.: purification, properties and detection in urine of infected patients. Infect. & Immunol., 1992, 6, 2267-2273.
8. Mutnick A.M., Turner P.J., Jones R.N.: Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. J. Chemother., 2002, 14 (3), 253-258.
9. NCCLS - Performance Standards for Antimicrobial Susceptbility Testing. Ninth Informational Supplement NCCLS Document, 1999, 19, 1.
10. Neuwirth C. i wsp.: Imipenem resistance in clinical isolates of Proteus mirabilis with alterations in penicillin-binding proteins. J. Antimicrob. Chemother., 1995, 36, 335-342.
11. Pagani L. i wsp.: Emerging Extended-Spectrum β-Lactamases in Proteus mirabilis. J. Clin. Microbiol., 2002, 4, 1549-1552.
12. Pitout J.D.D., Sanders C.C., Sanders W.E.: Antimicrobial resistance with focuson β-lactam resistance in Gram-negative Bacilli. Am. J. Med., 1997, 103, 51-59.
13. Różalski A.: Molecular basis of the pathogenicity of Proteus bacteria. Adv. Clin. Exp. Med., 2002, 11 (1), 3-18.
14. Różalski A. i wsp.: Molekularne podstawy chorobotwó rczości bakterii z rodzaju Proteus. Mikrob. Med., 1999, 1 (18), 3-16.
15. Ruczkowska J. iwsp.: Wrażliwość bakterii na fiuorochinolony. Post. Med. Klin. Dośw., 1994, 3 (4), 433-440.
16. Sachs L.: Applied statistics. Springer Verlag, Berlin 1982.
17. Sareneva T., Holthofer H., Korhonen T.: Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect. Immunol., 1990, 58, 3330-3336.
18. Senior B.W., Albrechtsen M., Kerr M.A.: The ureases of Proteus strains in relation to virulence for the urinary tract. J. Med. Microbiol., 1980, 13, 507-512.
19. Szymaniak L., Aleksandrowicz I., Giedrys-Kalemba S.: Lekoopornoś ć oraz typy pirocytogenne szczepów Proteus mirabilis izolowanych z zakażeń dróg moczowych. Med. Dośw. Mikrobiol., 1999, 51, 323-330.